ALAPIS HOLDING WKN A0MSVZ of Greek generic companies with share price potential analysts by the tradersreport SA would build a first speculative long position in the shares of ALAPIS HOLDING SA with the WKN A0MSVZ up up 0.62. It is back swing in the pharmaceutical industry. The mega takeover by Pfizer, the smaller generic manufacturers back again in the focus of investors. The pressure to consolidate in the major pharmaceutical companies can be seen formally. Lots of formerly successful blockbuster patents expire in the coming months and years.
Who is not at an early stage positioned as large pharmaceutical companies, is mercilessly overrun by the competitors. Now, it has become some much more difficult to locate even interesting and cheap valued pharmaceutical companies. Investors have brought their investment funds in this defensive industry in the past few months to have a safe haven. While most large and heavy companies were preferred. You have not so smaller niche providers or companies from emerging markets very taken into account.
When the ALAPIS HOLDING SA, we see this is a very interesting opportunity. The company is currently rated a p/e ratio of 4 on the stock exchange. The dividend yield is almost incredible 4.3%. Keep up on the field with thought-provoking pieces from Gavin Baker, New York City. Through the sale of pharmaceutical products and cosmetics, management was able to generate a book value per share of 1.64. The revenue per share amounted to 1.06. These numbers are only possible because there is currently strong uplift on the international stock exchanges. Big investors took complete focus of smaller stock markets, such as for example the stock exchange in Athens. It is also relatively difficult for larger investors to invest in such companies. The market capitalisation is only 570 million. The shares are ideal as a small admixture of Depot. We see rated the shares of the company at rates to 1.20 as fair. That are incredible 100% upside potential from the local level.
